Clinical efficacy and safety of buyang huanwu decoction for acute ischemic stroke: A systematic review and meta-analysis of 19 randomized controlled trials

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Hao, Chi Zi ^a   Wu, Fan ^b   Shen, Jiangang ^c   Lu, Lin ^b   Fu, Deng Lei ^b   Liao, Wei Jing ^a   Zheng, Guo Qing ^b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b THE SECOND AFFILIATED HOSPITAL AND YUYING CHILDREN S HOSPITAL OF WENZHOU MEDICAL UNIVERSITY   (China)

^c THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BUYANG HUANWU DECOCTION; CENTRAL NERVOUS SYSTEM AGENTS; CHINESE DRUG; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; DATA BASE; DATA SYNTHESIS; DRUG SAFETY; HUMAN; INFORMATION PROCESSING; META ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC DEFICIT SCORE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCORING SYSTEM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

EID: 84868697095     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/630124     Document Type: Review

References (44)

1. Feigin V. L., Lawes C. M. M., Bennett D. A., Anderson C. S., Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. The Lancet Neurology 2003 2 1 43 53 2-s2.0-0043013350 10.1016/S1474-4422(03)00266-7 (Pubitemid 37443343)
2. World Health Organization, STEPwise approach to stroke surveillance.
3. Johnston S. C., Mendis S., Mathers C. D., Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling. The Lancet Neurology 2009 8 4 345 354 2-s2.0-62149101015 10.1016/S1474-4422(09) 70023-7
4. Panagos P. D., The approach to optimizing stroke care. The American Journal of Emergency Medicine 2008 26 7 808 816 10.1016/j.ajem.2007.11.014
5. Liu Z., Guan L., Wang Y., Xie C. L., Lin X. M., Zheng G. Q., History and mechanism for treatment of intracerebral hemorrhage with scalp acupuncture. Evidence-Based Complementary and Alternative Medicine 2012 2012 9 895032 10.1155/2012/895032
6. Wang Q. R., Yilin Gaicuo 2005 Beijing, China People's Medical Publishing House
7. Wang H. W., Liou K. T., Wang Y. H., Lu C. K., Lin Y. L., Lee I. J., Huang S. T., Tsai Y. H., Cheng Y. C., Lin H. J., Shen Y. C., Deciphering the neuroprotective mechanisms of bu-yang huan-wu decoction by an integrative neurofunctional and genomic approach in ischemicstroke mice. Journal of Ethnopharmacology 2011 138 1 22 33 10.1016/j.jep.2011.06.033
8. Li X. M., Bai X. C., Qin L. N., Huang H., Xiao Z. J., Gao T. M., Neuroprotective effects of Buyang Huanwu decoction on neuronal injury in hippocampus after transient forebrain ischemia in rats. Neuroscience Letters 2003 346 1-2 29 32 2-s2.0-0038383786 10.1016/S0304-3940(03)00522-6 (Pubitemid 36792186)
9. Chen Y. S., Cheng W. C., Yao C. H., Hsieh C. L., Lin J. G., Lai T. Y., Lin C. C., Tsai C. C., Effects of buyang huanwu decoction on peripheral nerve regeneration using silicone rubber chambers. American Journal of Chinese Medicine 2001 29 3-4 423 432 2-s2.0-0035748065
10. Sun J., Bi Y., Guo L., Qi X., Zhang J., Li G., Tian G., Ren F., Li Z., Buyang huanwu decoction promotes growth and differentiation of neural progenitor cells: using a serum pharmacological method. Journal of Ethnopharmacology 2007 113 2 199 203 2-s2.0-34547766424 10.1016/j.jep.2007.05.018 (Pubitemid 47239243)
11. Cai G., Liu B., Liu W., Tan X., Rong J., Chen X., Tong L., Shen J., Buyang huanwu decoction can improve recovery of neurological function, reduce infarction volume, stimulate neural proliferation and modulate VEGF and Flk1 expressions in transient focal cerebral ischaemic rat brains. Journal of Ethnopharmacology 2007 113 2 292 299 2-s2.0-34547821365 10.1016/j.jep.2007.06. 007 (Pubitemid 47239253)
12. Zhang Y. K., Han X. Y., Che Z. Y., Effects of buyang huanwu tang combined with bone marrow mesenchymal stem cell transplantation on the expression of VEGF and Ki-67 in the brain tissue of the cerebral ischemia-reperfusion model rat. Journal of Traditional Chinese Medicine 2010 30 4 278 282 2-s2.0-79952255697
13. Jorgensen H. S., Nakayama H., Raaschou H. O., Vive-Larsen J., Stoier M., Olsen T. S., Outcome and time course of recovery in stroke. Part II: time course of recovery. The copenhagen stroke study. Archives of Physical Medicine and Rehabilitation 1995 76 5 406 412 2-s2.0-0029000430 10.1016/S0003-9993(95)80568-0
14. Hatano S., Experience from a multicentre stroke register: a preliminary report. Bulletin of the World Health Organization 1976 54 5 541 553 2-s2.0-0017205697 (Pubitemid 8114220)
15. The Second National Cerebrovascular Diseases Conference, Recommendations on clinical research in stroke. Chinese Journal of Neurology 1988 21 57 60
16. The Forth National Cerebrovascular Diseases Conference, Diagnostic criteria and disability scale for cerebrovascular diseases. Chinese Journal of Neurology 1996 29, article 379
17. The Forth National Cerebrovascular Diseases Conference, Classification, diagnostic criteria and evaluation of neurological impairment for stroke patients. Chinese Journal of Neurology 1996 29 381 383
18. Furlan A. D., Pennick V., Bombardier C., van Tulder M., 2009 Updated method guidelines for systematic reviews in the cochrane back review group. Spine 2009 34 18 1929 1941 2-s2.0-69749109780 10.1097/BRS.0b013e3181b1c99f
19. Guyatt G., Oxman A. D., Akl E. A., Kunz R., Vist G., Brozek J., Norris S., Falck-Ytter Y., Glasziou P., Debeer H., Jaeschke R., Rind D., Meerpohl J., Dahm P., Schünemann H. J., GRADE guidelines: 1. IntroductionGRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011 64 4 383 394 2-s2.0-79951952372 10.1016/j.jclinepi.2010.04.026
20. Guyatt G. H., Oxman A. D., Kunz R., Atkins D., Brozek J., Vist G., Alderson P., Glasziou P., Falck-Ytter Y., Schünemann H. J., GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011 64 4 395 400 2-s2.0-79951951792 10.1016/j.jclinepi.2010.09.012
21. Balshem H., Helfand M., Schünemann H. J., Oxman A. D., Kunz R., Brozek J., Vist G. E., Falck-Ytter Y., Meerpohl J., Norris S., Guyatt G. H., GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011 64 4 401 406 2-s2.0-79951955198 10.1016/j.jclinepi.2010.07.015
22. Guyatt G. H., Oxman A. D., Vist G., Kunz R., Brozek J., Alonso-Coello P., Montori V., Akl E. A., Djulbegovic B., Falck-Ytter Y., Norris S. L., Williams J. W. Jr., Atkins D., Meerpohl J., Schünemann H. J., GRADE guidelines: 4. Rating the quality of evidencestudy limitations (risk of bias). Journal of Clinical Epidemiology 2011 64 4 407 415 2-s2.0-79951955368 10.1016/j.jclinepi. 2010.07.017
23. Wu F. Y., Luo L. F., Influence of buyanghuanwu decoction on hs-CRP and MMP-9 of acute cerebral infarction Journal of Emergency in Traditional Chinese Medicine 2011 20 1 14 15
24. Zhang B. H., Observation of the effectiveness of buyang huanwu decoction on 40 cases of acute cerebral infarction Henan Traditional Chinese Medicine 2004 4 10 76 77
25. Guo L., The treatment of low molecular heparin calcium injection combined with buyanghuanwu decoction on 57 cases of acute cerebral infarction Modem Traditional Chinese Medicine 2009 29 5 3 4
26. Jia X. Q., Liu J. M., Wang X. F., Fan Z. Y., Tian N., A study on effect of buyang huanwu decoctionon caspase-3 in patients with cerebral infarction Chinese Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2010 17 4 209 211
27. Fang Y. S., Lin X. Y., Chen B. S., The eficiency and mechanism of buyanghuanwu decoction for cerebral infarction in patients with diabetes mellitus Chinese Journal of Integrative Medicine on Cardio-/Cerebrovascular Disease 2005 3 7 598 599
28. Zhang J. F., Yang Y. M., Xu D. H., Liu Z. W., A clinical analysis of treating cerebral infarction in the integrative medicine. Clinical Journal of Chinese Medicine 2012 1 4 16 18
29. Li Y. H., Hao X. M., Clinical observation of integrated Western medicine and buyang huanwu decoction on treating elderly cerebral infarction patients Chinese Joumal of Ethnomedicine and Ethnopharmacy 2011 13 112 113
30. Kang S. H., Clinical observation of integrated Western medicine and flavored buyang huanwu decoction in the treatment of acute cerebral infarction Medicine Industry Information 2006 3 21 117 118
31. Lin J. C., Observation of the effectiveness of buyang huanwu decoction on acute cerebral thrombosis Modern Journal of Integrated Traditional Chinese and Western Medicine 2008 17 32 4994 4995
32. Chen Y. J., Clinical observation of buyang huanwu decoction on acute cerebral infarction Liaoning Journal of Traditional Chinese Medicine 2007 34 10 1413 1414
33. Yan T. Z., Mei X. Y., Observation of effectiveness on treating acute cerebral infarction in the integrative medicine Hubei Journal of Traditional Chinese Medicine 2004 26 5, article 24
34. Cui L. L., An G., Yang H. F., The treatment of integrative medicine on 50 cases of acute cerebral infarction Journal of Shanxi College of Traditional Chinese Medicine 2005 6 1, article 36
35. Liu X. Y., Clinical observation on treating 55 cases of acute cerebral infarction in the integrative medicine Hebei Journal of Traditional Chinese Medicine 2010 32 1 76 77
36. Shi D. S., Zhang L. K., Clinical observation of buyang huanwu decoction on acute cerebral thrombosis Practical Journal of Integrated Traditional Chinese and Western Medicine 1995 8 4 228 229
37. Run Z. T., Observation of effectiveness of integrated Western medicine and buyang huanwu decoction on 24 cases of severe cerebral infarction Journal of Integrated Traditional and Western Medicine in Intensive and Critical Care 2001 8 2, article 104
38. Wang Y. Q., Yu D. F., The treatment of integrative medicine on 64 cases of cerebral infarction Fujian Journal of Traditional Chinese Medicine 2005 36 1 8 9
39. Lv G. F., The treatment integrated Western medicine and buyang huanwu decoction on 70 cases of acute Cerebral Infarction Clinical Journal of Traditional Chinese Medicine 2009 21 4 334 335
40. Zheng G. Y., Lin Z. Y., Chen X. D., Wei L. X., The Influence of buyanghuanwu decoction on the insulin and plasminogen activity in cerebral infarction patients Journal of Fujian College of Traditional Chinese Medicine 2004 14 6 11 13
41. Zhang Y. Q., Lu H., Tan W. L., Yang W. X., Liao X. F., Influence of buyanghuanwu decoction on clinical effect and blood flow of cerebral infarction with qi-defidency and blood-stasis syndrome Journal of Emergency in Traditional Chinese Medicine 2010 19 8 1288 1289
42. Wu B., Liu M., Liu H., Li W., Tan S., Zhang S., Fang Y., Meta-analysis of traditional Chinese patent medicine for ischemic stroke. Stroke 2007 38 6 1973 1979 2-s2.0-34249802628 10.1161/STROKEAHA.106.473165 (Pubitemid 46847279)
43. Wu B., Liu M., How to improve the quality of a clinical trial on traditional chinese medicine for stroke. Stroke 2009 40 11 e641 e642 2-s2.0-70350521858 10.1161/STROKEAHA.109.563072
44. Schulz K. F., Altman D. G., Moher D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. The British Medical Journal 2010 340, article c332 2-s2.0-77950362357 10.1136/bmj.c332